Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Adrenergic receptor alpha-1 | Starlite/ChEMBL | References |
Homo sapiens | glutamate receptor, ionotropic, N-methyl D-aspartate 2B | References | |
Homo sapiens | glutamate receptor, ionotropic, N-methyl D-aspartate 1 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | glutamate NMDA receptor subunit | 0.0115 | 0.6034 | 1 |
Echinococcus multilocularis | glutamate (NMDA) receptor subunit | 0.0115 | 0.6034 | 1 |
Echinococcus granulosus | glutamate receptor NMDA | 0.0095 | 0.3945 | 0.6537 |
Echinococcus multilocularis | nmda type glutamate receptor | 0.0104 | 0.491 | 0.8137 |
Echinococcus granulosus | nmda type glutamate receptor | 0.0113 | 0.5828 | 0.9658 |
Echinococcus multilocularis | glutamate receptor NMDA | 0.0095 | 0.3945 | 0.6537 |
Echinococcus multilocularis | nmda type glutamate receptor | 0.0113 | 0.5828 | 0.9658 |
Echinococcus granulosus | nmda type glutamate receptor | 0.0104 | 0.491 | 0.8137 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | > 30 mg kg-1 | Compound was evaluated in vivo for carrageenan induced mechanical hyperalgesia in rats, perorally | ChEMBL. | 15056006 |
Cl (ADMET) | = 8.3 ml min-1 kg-1 | Plasma clearance (in vivo) of the compound in rats was determined | ChEMBL. | 15056006 |
F (ADMET) | = 97 % | Oral bioavailability in rat | ChEMBL. | 15056006 |
IC50 (functional) | = 0.72 nM | In vitro inhibition of Glu/Gly stimulated [Ca2+] influx in LtK-cells expressing the hNR1a/NR2B receptor | ChEMBL. | 15056006 |
IC50 (functional) | = 0.72 nM | In vitro inhibition of Glu/Gly stimulated [Ca2+] influx in LtK-cells expressing the hNR1a/NR2B receptor | ChEMBL. | 15056006 |
IC50 (binding) | = 4000 nM | In vitro inhibitory activity against alpha-1 adrenergic receptor binding to rat brain membranes | ChEMBL. | 15056006 |
IC50 (binding) | = 4000 nM | In vitro inhibitory activity against alpha-1 adrenergic receptor binding to rat brain membranes | ChEMBL. | 15056006 |
IP (binding) | = 120 nM | In vitro inhibition of MK-499 binding to hERG in HEK293 cells | ChEMBL. | 15056006 |
IP (binding) | = 120 nM | In vitro inhibition of MK-499 binding to hERG in HEK293 cells | ChEMBL. | 15056006 |
Ki (binding) | = 0.68 nM | Compound was evaluated for in vitro inhibition of [3H]-[(E)-N-(2-methoxybenzyl)cinnamamidine binding to human NR1a/NR2B receptors expressed in LtK-cells | ChEMBL. | 15056006 |
Ki (binding) | = 0.68 nM | Compound was evaluated for in vitro inhibition of [3H]-[(E)-N-(2-methoxybenzyl)cinnamamidine binding to human NR1a/NR2B receptors expressed in LtK-cells | ChEMBL. | 15056006 |
T1/2 (ADMET) | > 118 min | Half-life of the compound in rats was determined | ChEMBL. | 15056006 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.